“…In Asian countries, such as Bhutan (3.9%), Malaysia (6.3%) and the Philippines (2.7%), anti-E2 positivity was significantly lower [43]. The prevalence of anti-E2 antibodies in HD patients has been established in several studies, with reported antibody rates of 12.9-29% in Germany [19,44], 22% in Austria [45], 14.2% in Belgium [46], 7% in Japan [18] and 15.6% in Taiwan [41]. Little data are available on patients on peritoneal dialysis treatment; however, rates ranging from 0 [20] to10.5% [21, 22] have been reported.…”